Healthcare costs have risen owing to highly priced pharmaceuticals, especially biologic drugs. Governments all over the world are emphasizing on the production of cost-effective drug synthesis. Estimates from Centers for Medicare and Medicaid Services state healthcare spending increased by 4.3% in the year 2016, amounting to over USD 3.3 trillion. These facts are indicative of the rising healthcare expenditure in the country and in the recent past, the government has been emphasizing on reducing healthcare expenditure. The implementation of Obamacare in the year 2010 has particularly been beneficial in accelerating market potential by reforming U.S. healthcare at large. Asian countries such as India, Japan, and China consist of large population bases and escalating healthcare costs are facilitating a gradual switch towards biosimilars. Various initiatives undertaken by national governments are expected to further expel market growth in the near future. Japan ranks second in the pharmaceutical market, following closely after the U.S. and various strategies undertaken by the government to evade the Asian economic crisis. Therefore, price regulations in Japan and price cuts formulated in India’s health budget have raised cost containment demands in healthcare industry at large. The current financial and economic crisis and the presence of a significant number of aging people are the key reasons to impose cost containment in healthcare systems. This brings to light the need for developing new, improved, and cost-effective methods for the synthesis of these drugs. Thus, the emphasis on bringing down the healthcare expenditure is expected to boost the market of biosimilars.

Second largest market in the CEE region. Per capita spending is below the CEE average. Slowest market growth in the CEE region, in US dollar terms. Other medical devices and consumables have the largest market shares.The market remains heavily reliant on imports. Turkey has a large number of manufacturers, but these tend to be small-scale, concentrating on cheap, low-technology items. In recent years, Turkey has focused on developing its healthcare system, with the goal of providing universal healthcare, although this is yet to be achieved. Over three quarters of total health expenditure comes from the public sector, primarily central & local governments and social security programmes.

Turkey's pharmaceutical market is the third-largest in the Central and Eastern Europe (CEE) region, due to its considerable population size. Turkey's pharmaceutical expenditure per capita, at USD115 in 2017, is considerably lower than any EU member state. It ranks just 20th out of the 32 countries in the CEE region, trailing most markets aside from the former Soviet CIS markets.

The UK’s telecom market remains one of the largest in Europe, characterised by fierce competition which has resulted in reduced pricing for end-users. Following some market consolidation in the mobile segment there are four key players and a number of MVNOs. Mobile broadband in coming years will place some additional pressure on the fixed-line broadband subscriber base as customers are tempted to migrate to 5G-enabled services. The fixed-line broadband sector is characterised by the steady decline in DSL and the ongoing efforts among a good number of operators to expand the reach of fibre networks. This is being supported by government efforts to encourage the right economic environment facilitating the ambition to have a fully-fibred UK by 2033. British Telecom is aiming to provide ultra-fast broadband services to some ten million premises by 2020, while Vodafone is also partnering with CityFibre to deliver an extensive 1Gb/s service to about five million premises by 2025.

Vietnam's insurance industry remains underdeveloped, with total premiums comprising only around 2% of overall GDP at present. Widespread poverty and low household incomes have limited the affordability of even basic property and motor products. As it is one of Asia's fastest-growing economies, we believe that there is potential for rapid growth across most lines over the next few years. In the personal insurance segment, increasing car ownership will support higher demand for motor insurance products, while fast growth in private healthcare usage will drive wealthier households to purchase health and personal accident insurance products. The fragmented nature of the market at present will also provide scope for mergers and acquisitions.

Generic drug markets will commoditise gradually through policies such as internal reference pricing, generic prescribing, generic substitution, and tendering. The introduction and enforcement of these guidelines will vary between countries, and are influenced by a variety of economic, political and cultural issues. Multinational manufacturers of generic drugs will therefore have to develop and employ a variety of market access strategies and operational campaigns.

Through state entities such as Bahrain Petroleum and the National Oil & Gas Authority, the government asserts primary control over the oil and gas sector in Bahrain. NOGA regulates the industry and issues regulations, while the state-owned oil and gas company BAPCO has exclusive rights to explore, produce and distribute oil and gas on the government's behalf. There is no key and overarching regulatory framework. However, the government has increasingly tried to increase private sector participation in order to maximise the country's limited natural resources (see Licensing Regime section below). In middle June 2016, King Hamad bin Isa al-Khalifa announced that he was abolishing the kingdom's Energy Ministry and creating two new portfolios from it. Sheikh Mohammed bin Khalifa bin Ahmed al-Khalifa was named Oil Minister and former Energy Minister Abdul Hussain bin Ali Mirza was appointed Electricity and Water Affairs Minister.

The Global Automotive Semiconductor Market is evolving along with the changing demographics of the automotive industry. In terms of revenue, the Global Automotive Semiconductor Market is expected to grow at a CAGR of 6.9% during 2017−2023. Semiconductors form the backbone of next-generation automotive technology. The rise of new technologies, rapid developments in the emerging markets, the adoption of sustainable policies, and changing consumer preferences is expected to exponentially increase the usage of semiconductors in vehicles. Moreover, digitization and change in business models have spurred a revolution in many industries including automotive. Disruptive technologies such as electrification, diverse mobility, autonomous driving, and rapidly evolving connectivity services are propelling the growth of the Global Automotive Semiconductor Market in recent years.

The automotive glass market has been segmented on the basis of product, application, enduse, and vehicle type. On the basis of product, the market has been segmented into laminated glass, tempered glass, and others. Other glasses include insulated glass and complex glass compositions used for special automotive. On the basis of application, the market has been segmented as windscreen, backlite, and sidelite. On the basis of end-use, the market has been segmented as OEM and ARG. On the basis of vehicle type, the market has been segmented as passenger cars, light commercial vehicles, and heavy commercial vehicles.

There are two types of batteries including primary and secondary. Primary batteries are the one that can be used only once whereas secondary batteries can be charged and reused. Various batteries include lead acid, nickel cadmium, lithium ion, nickel metal hydride, and alkaline.